Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Impact of learning HIV status on contraceptive use in the MIRA trial.

Blanchard K, Holt K, Bostrom A, van der Straten A, Ramjee G, de Bruyn G, Chipato T, Montgomery ET, Padian NS.

J Fam Plann Reprod Health Care. 2011 Oct;37(4):204-8. doi: 10.1136/jfprhc-2011-0109. Epub 2011 Jul 11.

PMID:
21746799
2.

Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services.

Kaida A, Laher F, Strathdee SA, Money D, Janssen PA, Hogg RS, Gray G.

PLoS One. 2010 Nov 5;5(11):e13868. doi: 10.1371/journal.pone.0013868.

3.

The use of the diaphragm instead of condoms in a phase III diaphragm trial.

van der Straten A, Cheng H, Moore J, Kacanek D, Blanchard K, De Bruyn G, Ramjee G, Chipato T, Montgomery ET, Padian N; MIRA Team.

AIDS Behav. 2009 Jun;13(3):564-72. doi: 10.1007/s10461-008-9504-z. Epub 2008 Dec 16.

PMID:
19085099
4.

[Current status of the female condom in Africa].

Deniaud F.

Sante. 1997 Nov-Dec;7(6):405-15. Review. French.

PMID:
9503499
5.

A family planning intervention to reduce vertical transmission of HIV in Rwanda.

King R, Estey J, Allen S, Kegeles S, Wolf W, Valentine C, Serufilira A.

AIDS. 1995 Jul;9 Suppl 1:S45-51.

PMID:
8562000
6.

HIV infection in women: impact on contraception.

Magalhães J, Amaral E, Giraldo PC, Simoes JA.

Contraception. 2002 Aug;66(2):87-91.

PMID:
12204780
7.

The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic.

Young LK, Farquhar CM, McCowan LM, Roberts HE, Taylor J.

N Z Med J. 1994 May 25;107(978):189-92.

PMID:
8196861
8.

Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe.

van der Straten A, Cheng H, Minnis AM.

J Int AIDS Soc. 2010 Oct 19;13:39. doi: 10.1186/1758-2652-13-39.

9.

Factors impacting knowledge and use of long acting and permanent contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: a cross-sectional study.

Credé S, Hoke T, Constant D, Green MS, Moodley J, Harries J.

BMC Public Health. 2012 Mar 16;12:197. doi: 10.1186/1471-2458-12-197.

10.

Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi.

Anand A, Shiraishi RW, Bunnell RE, Jacobs K, Solehdin N, Abdul-Quader AS, Marum LH, Muttunga JN, Kamoto K, Aberle-Grasse JM, Diaz T.

AIDS. 2009 Jul 31;23(12):1565-73. doi: 10.1097/QAD.0b013e32832cb10c.

PMID:
19542867
11.

Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe.

van der Straten A, Moore J, Napierala S, Clouse K, Mauck C, Hammond N, Padian N.

Contraception. 2008 Jun;77(6):435-43. doi: 10.1016/j.contraception.2008.02.013. Epub 2008 Apr 24.

PMID:
18477494
12.

Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia.

Haddad L, Wall KM, Vwalika B, Khu NH, Brill I, Kilembe W, Stephenson R, Chomba E, Vwalika C, Tichacek A, Allen S.

AIDS. 2013 Oct;27 Suppl 1:S93-103. doi: 10.1097/QAD.0000000000000039.

14.

Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe.

van der Straten A, Kang MS, Posner SF, Kamba M, Chipato T, Padian NS.

Sex Transm Dis. 2005 Jan;32(1):64-71.

PMID:
15614123
15.

[Contraceptive use and incidence of pregnancy among women after HIV testing in Abidjan, Ivory Coast].

Brou H, Viho I, Djohan G, Ekouévi DK, Zanou B, Leroy V, Desgrées-du-Loû A; pour le groupe Ditrame Plus ANRS 1202/1201/1253.

Rev Epidemiol Sante Publique. 2009 Apr;57(2):77-86. doi: 10.1016/j.respe.2008.12.011. Epub 2009 Mar 21. French.

PMID:
19304422
16.

Protecting against both pregnancy and disease: predictors of dual method use among a sample of women.

Harvey SM, Henderson JT, Branch MR.

Women Health. 2004;39(1):25-43.

PMID:
15002881
17.

User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.

Sahin-Hodoglugil NN, Montgomery E, Kacanek D, Morar N, Mtetwa S, Nkala B, Philip J, Ramjee G, Cheng H, van der Straten A, The Mira Team.

AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.

PMID:
21480005
18.

Establishing a continuum of care between HIV prevention trials and public healthcare systems: the MIRA Standard of Care program.

Clouse K, Montgomery ET, Milford C, Watadzaushe C, Nkala B, Fancher H, Lince N, Cheng H, Thompson M, van der Straten A.

Clin Trials. 2010 Jun;7(3):256-64. doi: 10.1177/1740774510368299. Epub 2010 Apr 26.

PMID:
20421242
19.

A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.

Kacanek D, Dennis A, Sahin-Hodoglugil NN, Montgomery ET, Morar N, Mtetwa S, Nkala B, Phillip J, Watadzaushe C, van der Straten A; Mira Team.

AIDS Educ Prev. 2012 Feb;24(1):54-67. doi: 10.1521/aeap.2012.24.1.54.

PMID:
22339145
20.

Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa.

Montgomery ET, Blanchard K, Cheng H, Chipato T, de Bruyn G, Ramjee G, Padian N, van der Straten A; MIRA team.

Eur J Contracept Reprod Health Care. 2009 Dec;14(6):410-9. doi: 10.3109/13625180903215430.

PMID:
19929644
Items per page

Supplemental Content

Write to the Help Desk